Sonazoid-enhanced Ultrasound in the Diagnosis and Treatment of Hepatic Tumors

Sonazoid, a second-generation contrast agent, was approved for exclusive use in Japan in 2007. This agent has two extremely favorable features: (1) real-time vascular imaging ability, and (2) an extremely stable Kupffer phase in the postvascular phase for 10–60 minutes allowing multiple scanning. With these favorable features, differential diagnosis of hepatic tumors using Sonazoid-enhanced ultrasound (US) has been compared with Levovist-enhanced US or multidetector computed tomography (MDCT). Furthermore, a new technique, “defect reperfusion imaging” has made it possible to depict and diagnose nodules, which are not identified by B-mode US but are detected by MDCT. Thus, Sonazoid-enhanced US is a breakthrough technology in the diagnosis and treatment of hepatic tumors.

[1]  M. D’Onofrio,et al.  Focal liver lesions: sinusoidal phase of CEUS , 2006, Abdominal Imaging.

[2]  M. Kudo,et al.  Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agent. , 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  J M Rubin,et al.  Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. , 1994, Radiology.

[4]  M. Kudo,et al.  Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. , 2004, AJR. American journal of roentgenology.

[5]  Kinuyo Hatanaka,et al.  Differential Diagnosis of Hepatic Tumors: Value of Contrast-Enhanced Harmonic Sonography Using the Newly Developed Contrast Agent, Sonazoid , 2008, Intervirology.

[6]  M. Kudo.  Morphological diagnosis of hepatocellular carcinoma: special emphasis on intranodular hemodynamic imaging. , 1998, Hepato-gastroenterology.

[7]  Kazushi Numata,et al.  Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. , 2003, Radiology.

[8]  K. Koito,et al.  Differential diagnosis of small hepatocellular carcinoma and adenomatous hyperplasia with power Doppler sonography. , 1998, AJR. American journal of roentgenology.

[9]  M. Kudo.  Imaging Diagnosis of Hepatocellular Carcinoma and Premalignant/Borderline Lesions , 1999, Seminars in liver disease.

[10]  M. Kudo,et al.  Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. , 1992, AJR. American journal of roentgenology.

[11]  Fuminori Moriyasu,et al.  Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. , 2007, Ultrasound in medicine & biology.

[12]  M. Fujita,et al.  Color Doppler flow imaging of liver tumors. , 1990, AJR. American journal of roentgenology.

[13]  R. Manfredi,et al.  New prospects for ultrasound contrast agents. , 1998, European journal of radiology.

[14]  正俊 工藤,et al.  肝細胞癌治療支援におけるSonazoid造影エコー法の新技術の提唱：Defect Re-perfusion Imagingの有用性 , 2007 .

[15]  O. Matsui,et al.  Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. , 1991, Radiology.

[16]  I. Wanless,et al.  On the pathogenesis of focal nodular hyperplasia of the liver , 1985, Hepatology.

[17]  Masatoshi Kudo,et al.  Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Manual Proposed by the Japan Society of Hepatology , 2007, Oncology.

[18]  M. Kudo,et al.  Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. , 2001, Radiology.

[19]  M. Makuuchi,et al.  Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma , 1990, The Lancet.

[20]  M. Fujita,et al.  Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging. , 1992, Radiology.

[21]  L. Hoff,et al.  Acoustic properties of NC100100 and their relation with the microbubble size distribution. , 1999, Investigative radiology.